Bayer (BAYN) Reaches New 1-Year Low at $54.31

Bayer AG (ETR:BAYN) reached a new 52-week low during trading on Thursday . The stock traded as low as €54.31 ($63.15) and last traded at €54.47 ($63.34), with a volume of 859284 shares changing hands. The stock had previously closed at €55.85 ($64.94).

The company has a debt-to-equity ratio of 87.64, a current ratio of 1.37 and a quick ratio of 0.91. The company has a market capitalization of $53.39 billion and a PE ratio of 53.67.

ILLEGAL ACTIVITY WARNING: This story was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at

About Bayer (ETR:BAYN)

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Read More: How Do Mutual Funds Work?

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with's FREE daily email newsletter.